Abgent, a WuXi AppTec company, is a leading manufacturer of primary antibodies with more than fifteen years of experience.

Abgent offers more than 65 000 primary antibodies with focus on major research areas impacting health and disease, including Cancer, Metabolism, Cardiovascular, Neuroscience, and Stem cells and offer.

Company highlights:

• Most antibodies are produced in-house to ensure specificity, affinity, and reproducibility.
• Over 1 000 new antibodies are released per year with an emphasis on autophagy, stem cells, and neurodegeneration.
• Striving for proteome-wide antibody coverage.
• Featuring our "Crown" line of premium antibodies and offering evaluation size vials for more than 10 000 products.